Medical Electronics
Surface and light cure cyanoacrylate adhesives
Cyanoacrylate adhesives (CAs) are strong, fast curing products for interfacial bonding applications, but they don’t tend to cure effectively when not between two surfaces. To overcome this, manufacturers can use a chemical activator to encourage fast cure. However, the downsides of activators have sometimes meant precluding the use of CAs in medical electronics applications like hearing aids and wearable devices, despite their other advantages. Here Darren Rea, internal sales executive at adhesives supplier Intertronics, discusses how new technology can remove the need for activators in CA bonding processes, making them a more attractive option for medical electronic assemblies
C
As cure best interfacially — i.e., between two surfaces — and in thin bondlines. In adhesive joint formats where there are exposed surfaces,
fillets or where squeeze out occurs, cure can take a long time. In these cases, manufacturers can use a chemical activator to encourage the adhesive to cure, to ensure they can still benefit from the fast- curing feature of CA materials.
The disadvantages of activators The use of an activator has several downsides, one of which is that it is an extra process. An activator is another chemical to contend with, adding health and safety and risk assessment reviews, and stock management and shelf-life processes. They are often solvented. Activators are typically applied by spraying, using an aerosol can or spray valve. At a time when many companies are working hard to improve safety and the environment by removing solvents and other chemicals, activators are not an appealing option.
Medical electronics manufacturing companies may require their cured assembly adhesives to pass a cytotoxicity test like ISO 10993, and have tightly controlled and validated processes. The spraying of an activator, especially from an aerosol can, is tricky to control. Questions have been asked about overspray, how that extra chemical is reacted, and if there are unacceptable levels of contamination around the bondline. Most of this type of assembly is done in a cleanroom, where spraying is anathema.
22 December/January 2022
Out with activators, in with UV Recent innovation has led to the introduction of new adhesives that represent a big step forward in cyanoacrylate adhesive technology. Products in the Born2Bond range overcome many of the performance and application limitations of existing CA products, while also facilitating faster, smarter production processes. The range features safer products, with fewer or no label hazard symbols.
The new range introduces a straightforward way to remove the need for activators when working with exposed bondlines — Born2Bond Light
Components in Electronics
Lock. This unique material is the first low-odour, low-bloom, light curing cyanoacrylate adhesive. Its dual cure formulation includes both conventional “instant” (surface) cure and light cure for the rapid curing of exposed fillets or areas, as well as through transparent parts. The material solves the traditional challenge of curing outside of the bond line, offering a fixture time of around 60 seconds without light exposure, or less than five seconds with low power visible or long wave UV light.
Light Lock dispensing processes are easy to automate and validate, a benefit for the medical electronics
sector. Light Lock is ISO 10993-5 and ISO 10993-10 tested and therefore suitable for consideration in medical electronics manufacturing for applications including ruggedising, wire tacking, encapsulating, insulating, and coating. Manufacturers can purchase the material in high viscosity and gel formulations for bonding, repair, coating or infilling applications.
With new materials like Light Lock, medical electronics manufacturers can consider using CAs, realising the benefits of UV and CA technology in one product.
www.intertronics.co.uk www.cieonline.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66
